Brain tumor tissue microarray,containing 96 cases of tumor (47 astrocytoma, 41 glioblastoma, 3 malignant ependymocytoma, 2 each of malignant ganglioglioma and glioma sarcomatosum, 1 medulloblastoma), 28 cases in mid stage, 68 in advanced stage, duplicate cores per case, divided into two identical 96 core arrays, suitable for therapeutic antibody screening.
Brain tumor tissue microarray, containing 96 cases of tumor (47 astrocytoma, 41 glioblastoma, 3 ependymoma, 2 each of ganglion glioma and gliosarcoma, 1 medulloblastoma), duplicate cores per case, divided into two identical 96 core arrays, suitable for therapeutic antibody screening.
Breast carcinoma tissue microarray, containing 8 each case of invasive carcinoma of no special type, mucinous carcinoma, cystosarcoma phyllodes and fibroadenoma, 6 medullary carcinoma, 4 Paget's disease, 2 carcinosarcoma, 6 cancer adjacent breast tissue, duplicate cores per case
Breast carcinoma tissue microarray, containing 75 cases of breast invasive carcinoma of no special type, duplicate cores per case (duplicated cores from the same patient were put onto upper and lower rows in the same position)
Breat invasivecarcinoma of no special type tissue microarray, containing 48 cases of breast invasive carcinoma of no special type, single core per case
Brain tumor tissue microarray, containing 96 cases of tumor (47 astrocytoma, 41 glioblastoma, 3 ependymoma, 2 each of ganglion glioma and gliosarcoma, 1 medulloblastoma), duplicate cores per case, divided into two identical 96 core arrays, suitable for therapeutic antibody screening.